Business
Press Release Jan 06 2021
Lupin Limited has informed the Exchange regarding a press release dated January 06, 2021, titled "Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated January 06, 2021, titled \"Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.\". View Attachment","length":350,"tagName":"div"}]